C. Ronald Kahn
Dr. C. Ronald Kahn is a prominent professor of medicine at Harvard University and serves as the chief academic officer at Harvard’s Joslin Diabetes Center. He is well-regarded for his research in diabetes and obesity, particularly in understanding the mechanisms of insulin action and resistance. Dr. Kahn has expressed the importance of developing oral weight-loss medications, emphasizing that many patients prefer pills over injections, which aligns with the growing interest in weight-loss treatments like Eli Lilly's orforglipron, a drug recently highlighted for its efficacy in clinical trials.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Australia | 1 | 8.00 | 0.05% | +0% | 25,499,884 | 12,439 | $1,380,000 | 673$ |
| Totals | 1 | 25,499,884 | 12,439 | $1,380,000 | 673$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Dr. C. Ronald Kahn is a professor of medicine at Harvard University and chief academic officer at Harvard’s Joslin Diabetes Center.
8